federal_register: 2012-25503
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-25503 | Oncologic Drugs Advisory Committee; Cancellation | Notice | The meeting of the Oncologic Drugs Advisory Committee Meeting scheduled for November 8, 2012, is canceled. This cancellation applies to both the morning session and afternoon session of the meeting. This meeting was announced in the Federal Register of September 20, 2012 (77 FR 58399). The issues for which the FDA was seeking the scientific input of the committee have been resolved. | 2012-10-17 | 2012 | 10 | https://www.federalregister.gov/documents/2012/10/17/2012-25503/oncologic-drugs-advisory-committee-cancellation | https://www.govinfo.gov/content/pkg/FR-2012-10-17/pdf/2012-25503.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The meeting of the Oncologic Drugs Advisory Committee Meeting scheduled for November 8, 2012, is canceled. This cancellation applies to both the morning session and afternoon session of the meeting. This meeting was announced in the Federal Register of... |